Report Detail

Request for Sample of this report

Pharma & Healthcare Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Professional Survey Report 2019

  • RnM3796170
    • |
  • 01 October, 2019
    • |
  • Global
    • |
  • 105 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin America are expected to impede growth of the global dermatophytic onychomycosis therapeutics market.
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market. By treatment, the market is segmented into topical and oral therapy. Among these, the topical segment is anticipated to be dominant throughout the forecast period and projected to account for about 70% share of the total global dermatophytic onychomycosis market revenue by 2025.

The global Dermatophytic Onychomycosis Therapeutics (DOT) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Dermatophytic Onychomycosis Therapeutics (DOT) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dermatophytic Onychomycosis Therapeutics (DOT) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Dermatophytic Onychomycosis Therapeutics (DOT) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Dermatophytic Onychomycosis Therapeutics (DOT) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Galderma
Bausch Health
Novartis
Pfizer
Janssen
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Topical
Oral Therapy

Segment by Application
Hospitals
Dermatology And Podiatry Clinics
Independent Pharmacies
Mail Order Pharmacies
Drug Stores


Table of Contents

    Executive Summary

      1 Industry Overview of Dermatophytic Onychomycosis Therapeutics (DOT)

      • 1.1 Definition of Dermatophytic Onychomycosis Therapeutics (DOT)
      • 1.2 Dermatophytic Onychomycosis Therapeutics (DOT) Segment by Type
        • 1.2.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Topical
        • 1.2.3 Oral Therapy
      • 1.3 Dermatophytic Onychomycosis Therapeutics (DOT) Segment by Applications
        • 1.3.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Dermatology And Podiatry Clinics
        • 1.3.4 Independent Pharmacies
        • 1.3.5 Mail Order Pharmacies
        • 1.3.6 Drug Stores
      • 1.4 Global Dermatophytic Onychomycosis Therapeutics (DOT) Overall Market
        • 1.4.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue (2014-2025)
        • 1.4.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production (2014-2025)
        • 1.4.3 North America Dermatophytic Onychomycosis Therapeutics (DOT) Status and Prospect (2014-2025)
        • 1.4.4 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Status and Prospect (2014-2025)
        • 1.4.5 China Dermatophytic Onychomycosis Therapeutics (DOT) Status and Prospect (2014-2025)
        • 1.4.6 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Status and Prospect (2014-2025)
        • 1.4.8 India Dermatophytic Onychomycosis Therapeutics (DOT) Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Dermatophytic Onychomycosis Therapeutics (DOT)
      • 2.3 Manufacturing Process Analysis of Dermatophytic Onychomycosis Therapeutics (DOT)
      • 2.4 Industry Chain Structure of Dermatophytic Onychomycosis Therapeutics (DOT)

      3 Development and Manufacturing Plants Analysis of Dermatophytic Onychomycosis Therapeutics (DOT)

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Dermatophytic Onychomycosis Therapeutics (DOT)
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Dermatophytic Onychomycosis Therapeutics (DOT) Production and Capacity Analysis
      • 4.2 Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Analysis
      • 4.3 Dermatophytic Onychomycosis Therapeutics (DOT) Price Analysis
      • 4.4 Market Concentration Degree

      5 Dermatophytic Onychomycosis Therapeutics (DOT) Regional Market Analysis

      • 5.1 Dermatophytic Onychomycosis Therapeutics (DOT) Production by Regions
        • 5.1.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production by Regions
        • 5.1.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue by Regions
      • 5.2 Dermatophytic Onychomycosis Therapeutics (DOT) Consumption by Regions
      • 5.3 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Analysis
        • 5.3.1 North America Dermatophytic Onychomycosis Therapeutics (DOT) Production
        • 5.3.2 North America Dermatophytic Onychomycosis Therapeutics (DOT) Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Dermatophytic Onychomycosis Therapeutics (DOT) Import and Export
      • 5.4 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Analysis
        • 5.4.1 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Production
        • 5.4.2 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Import and Export
      • 5.5 China Dermatophytic Onychomycosis Therapeutics (DOT) Market Analysis
        • 5.5.1 China Dermatophytic Onychomycosis Therapeutics (DOT) Production
        • 5.5.2 China Dermatophytic Onychomycosis Therapeutics (DOT) Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Dermatophytic Onychomycosis Therapeutics (DOT) Import and Export
      • 5.6 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Analysis
        • 5.6.1 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Production
        • 5.6.2 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Import and Export
      • 5.7 Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Analysis
        • 5.7.1 Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Production
        • 5.7.2 Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Import and Export
      • 5.8 India Dermatophytic Onychomycosis Therapeutics (DOT) Market Analysis
        • 5.8.1 India Dermatophytic Onychomycosis Therapeutics (DOT) Production
        • 5.8.2 India Dermatophytic Onychomycosis Therapeutics (DOT) Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Dermatophytic Onychomycosis Therapeutics (DOT) Import and Export

      6 Dermatophytic Onychomycosis Therapeutics (DOT) Segment Market Analysis (by Type)

      • 6.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Production by Type
      • 6.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue by Type
      • 6.3 Dermatophytic Onychomycosis Therapeutics (DOT) Price by Type

      7 Dermatophytic Onychomycosis Therapeutics (DOT) Segment Market Analysis (by Application)

      • 7.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Consumption by Application
      • 7.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Consumption Market Share by Application (2014-2019)

      8 Dermatophytic Onychomycosis Therapeutics (DOT) Major Manufacturers Analysis

      • 8.1 Galderma
        • 8.1.1 Galderma Dermatophytic Onychomycosis Therapeutics (DOT) Production Sites and Area Served
        • 8.1.2 Galderma Product Introduction, Application and Specification
        • 8.1.3 Galderma Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Bausch Health
        • 8.2.1 Bausch Health Dermatophytic Onychomycosis Therapeutics (DOT) Production Sites and Area Served
        • 8.2.2 Bausch Health Product Introduction, Application and Specification
        • 8.2.3 Bausch Health Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Novartis
        • 8.3.1 Novartis Dermatophytic Onychomycosis Therapeutics (DOT) Production Sites and Area Served
        • 8.3.2 Novartis Product Introduction, Application and Specification
        • 8.3.3 Novartis Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Pfizer
        • 8.4.1 Pfizer Dermatophytic Onychomycosis Therapeutics (DOT) Production Sites and Area Served
        • 8.4.2 Pfizer Product Introduction, Application and Specification
        • 8.4.3 Pfizer Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Janssen
        • 8.5.1 Janssen Dermatophytic Onychomycosis Therapeutics (DOT) Production Sites and Area Served
        • 8.5.2 Janssen Product Introduction, Application and Specification
        • 8.5.3 Janssen Dermatophytic Onychomycosis Therapeutics (DOT) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served

      9 Development Trend of Analysis of Dermatophytic Onychomycosis Therapeutics (DOT) Market

      • 9.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Trend Analysis
        • 9.1.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Dermatophytic Onychomycosis Therapeutics (DOT) Regional Market Trend
        • 9.2.1 North America Dermatophytic Onychomycosis Therapeutics (DOT) Forecast 2019-2025
        • 9.2.2 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Forecast 2019-2025
        • 9.2.3 China Dermatophytic Onychomycosis Therapeutics (DOT) Forecast 2019-2025
        • 9.2.4 Japan Dermatophytic Onychomycosis Therapeutics (DOT) Forecast 2019-2025
        • 9.2.5 Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Forecast 2019-2025
        • 9.2.6 India Dermatophytic Onychomycosis Therapeutics (DOT) Forecast 2019-2025
      • 9.3 Dermatophytic Onychomycosis Therapeutics (DOT) Market Trend (Product Type)
      • 9.4 Dermatophytic Onychomycosis Therapeutics (DOT) Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Dermatophytic Onychomycosis Therapeutics (DOT) Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Dermatophytic Onychomycosis Therapeutics (DOT). Industry analysis & Market Report on Dermatophytic Onychomycosis Therapeutics (DOT) is a syndicated market report, published as Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Dermatophytic Onychomycosis Therapeutics (DOT) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        		$3,500.00
        		$5,250.00
        		$7,000.00
        		2,705.50
        		4,058.25
        		5,411.00
        		3,258.50
        		4,887.75
        		6,517.00
        		534,415.00
        		801,622.50
        		1,068,830.00
        		295,400.00
        		443,100.00
        		590,800.00
        Credit card Logo
        Sample Question Discount Download PDF

        Related Reports

        Reason to Buy

        • Trusted By Leaders

          Top executives from leading companies purchase research reports from us. 

        • Shop With Confidence

          We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

        • Customer Centric

          Need assistance related to your research requirements? We are just a phone call or an email away.

        • Personalized Solutions

          Our experienced research specialists are here to help you locate the right reports for your need.

        • Secure Checkout

          Shop without being worried about safety & security of your transactions.
          •

        Request for Sample of this report

        Reports and Markets

        mcafree

        Contact Us

        +1-352-353-0818 (US)

        info@reportsandmarkets.com

        Support

        EMAIL US

        Newsletter

        KEEP UP TO DATE ON ALL THE LATEST REPORTS


        maxmind_logo